LIVE, FREE and EXCLUSIVE
epa11096743 A nurse prepares to vaccinate a child against malaria in Nyalla Medical Centre in Douala, Cameroon, 22 January 2024. A new malaria vaccine, known as RTS,S, or Mosquirix, made by GlaxoSmithKline, is being rolled out for the first time as an immunization campaign for children in Cameroon. According to the World Health Organisation, the WHO African Region, with an estimated 233 million cases in 2022, accounted for about 94% of cases globally. Malaria is highly endemic in Cameroon and the WHO estimates that about 11,000 people die from malaria in Cameroon every year. EPA/DONGMO RODRIGUE WILLIAM Source: EPA / DONGMO RODRIGUE WILLIAM/EPA
Published
Updated
By Achol Arok
Presented by Yasmeen Ahmed
Source: SBS
Share this with family and friends
The national campaign comes after a successful pilot phase in Kenya, Ghana and Malawi that saw a 13% drop in malaria deaths.
Kempen iba curu goíjje zéíte neíki pilot phase Kenya,Ghana ar Malawi ít 13% malaria ár zoriya mout homyé.
SBS RohingyaIndependent news and stories connecting you to life in Australia and Rohingya-speaking Australians.
SBS Learn EnglishEase into the English language and Australian culture. We make learning English convenient, fun and practical.Get the latest with our exclusive in-language podcasts on your favourite podcast apps.
